Home

Larimar Therapeutics, Inc. - Common Stock (LRMR)

4.2400
+0.00 (0.00%)
NASDAQ · Last Trade: Oct 16th, 4:42 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – LRMR
The DJS Law Group announces that it is investigating claims on behalf of investors of Larimar Therapeutics, Inc. (“Larimar” or “the Company”) (NASDAQ: LRMR) for violations of the securities laws.
By DJS Law Group · Via Business Wire · October 15, 2025
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Larimar Therapeutics, Inc. (“Larimar” or “the Company”) (NASDAQ: LRMR) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · October 15, 2025
Larimar Therapeutics Inc. (NASDAQ: LRMR) Leading the Way in Tuesday Trading Based on Percentage Gain
Larimar Therapeutics, Inc. (NASDAQ: LRMR) is one of today’s top gainers. The company’s shares have moved 25.16% on the day to $9.8.
Via Investor Brand Network · February 13, 2024
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Investor Alert: Investigation over Potential Wrongdoingsbwire.com
San Diego, CA -- (SBWIRE) -- 05/02/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Larimar Therapeutics, Inc.
Via SBWire · May 2, 2022
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Investor Notice: Investigation over Possible Violations of Securities Lawssbwire.com
San Diego, CA -- (SBWIRE) -- 03/02/2022 -- Larimar Therapeutics, Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Via SBWire · March 2, 2022
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Larimar Therapeutics, Inc. (LRMR) Investigation
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Larimar Therapeutics, Inc. (“Larimar” or the “Company”) (NASDAQ: LRMR). Investors who purchased Larimar shares are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/lrmr.
By Bronstein, Gewirtz & Grossman, LLC · Via Business Wire · February 17, 2022
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Larimar Therapeutics, Inc. (LRMR) Investigation
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Larimar Therapeutics, Inc. (“Larimar” or the “Company”) (NASDAQ: LRMR). Investors who purchased Larimar shares are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/lrmr.
By Bronstein, Gewirtz & Grossman, LLC · Via Business Wire · February 16, 2022